{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:30:37Z","timestamp":1789047037927,"version":"build-2803163510"},"reference-count":40,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100031918","name":"State Key Laboratory of Natural and Biomimetic Drugs","doi-asserted-by":"publisher","award":["KF2025020"],"award-info":[{"award-number":["KF2025020"]}],"id":[{"id":"10.13039\/100031918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373921"],"award-info":[{"award-number":["82373921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473769"],"award-info":[{"award-number":["82473769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2321004"],"award-info":[{"award-number":["T2321004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U25A20175"],"award-info":[{"award-number":["U25A20175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine","award":["712025001"],"award-info":[{"award-number":["712025001"]}]},{"name":"Shandong Basic Research Special Zone","award":["TQ052025001"],"award-info":[{"award-number":["TQ052025001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hyperuricemia-induced gout is largely driven by impaired renal urate excretion, while current URAT1 inhibitors suffer from OAT1-mediated off-target toxicity. Our lead compound E1 potently inhibited URAT1 (IC50 = 3.02 \u03bcM) and reduced serum uric acid but exhibited OAT1 inhibition (IC50 = 4.78 \u03bcM) and HK-2 cytotoxicity (CC50 = 46.22 \u03bcM). To improve selectivity while retaining the core pharmacophore, a nitrogen-walk strategy was applied to design 48 azaindole derivatives. Pyrrolo[3,2-d]pyrimidine-based compound 17 was identified as the optimized candidate, exhibiting URAT1 inhibition (IC50 = 5.32 \u03bcM) with reduced OAT1 inhibition (IC50 = 30.11 \u03bcM), achieving a 6.7-fold selectivity improvement over E1. Compound 17 reduced serum uric acid by 77.7% at 2 mg\/kg in an acute hyperuricemia mouse model and alleviated hepatic and renal injury in a chronic hyperuricemia model. It exhibited favorable druggability, including 87.9% oral bioavailability, a minimum effective dose below 0.5 mg\/kg, and no observable toxicity up to 1000 mg\/kg.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01923","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:02:17Z","timestamp":1786723337000},"page":"20911-20942","source":"Crossref","is-referenced-by-count":0,"title":["Rational Design\nof Azaindole Derivatives via a Nitrogen-Walk\nStrategy from \u03b2-Carboline: Discovery of Highly Selective,\nLow-Toxicity URAT1 Inhibitors as Potent Urate-Lowering Agents"],"prefix":"10.1021","volume":"69","author":[{"given":"Yuxin","family":"Jiang","sequence":"first","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shi","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Wu","sequence":"additional","affiliation":[{"name":"Southern Medical University , , 1838 North Guangzhou Ave , , ,","place":["Guangzhou, Guangdong, P. R. China, 510515"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Xu","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqi","family":"Yu","sequence":"additional","affiliation":[{"name":"Southern Medical University , , 1838 North Guangzhou Ave , , ,","place":["Guangzhou, Guangdong, P. R. China, 510515"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-2528","authenticated-orcid":true,"given":"Mei","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Meng","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[{"name":"Southern Medical University , , 1838 North Guangzhou Ave , , ,","place":["Guangzhou, Guangdong, P. R. China, 510515"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0053-2723","authenticated-orcid":true,"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[{"name":"Southern Medical University , , 1838 North Guangzhou Ave , , ,","place":["Guangzhou, Guangdong, P. R. China, 510515"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yi","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-6026","authenticated-orcid":true,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 West Culture Road , , ,","place":["Jinan, Shandong, P. R. China, 250012"]},{"name":"Peking University , , 38 Xue Yuan Rd , ,","place":["Beijing, P. R. China, 100191"]},{"name":"State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine (Tianjin Institute of Pharmaceutical Research) , ,","place":["Tianjin, P. R. China, 300301"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"2026091008471102100_cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108615","article-title":"Uric acid\nin health and disease:\nFrom physiological functions to pathogenic mechanisms","volume":"256","author":"Wen","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"2026091008471102100_cit2","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/ANNALS-24-03951","article-title":"Gout","volume":"178","author":"FitzGerald","year":"2025","journal-title":"Ann.\nInt. Med."},{"key":"2026091008471102100_cit3","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Global, regional, and\nnational burden of gout, 1990\u20132020, and projections to 2050:\na systematic analysis of the Global Burden of Disease Study 2021","volume":"6","author":"Ong","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"2026091008471102100_cit4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/HJH.0000000000001980","article-title":"Uric acid\nand hypertension: a focused review and practical recommendations","volume":"37","author":"De Becker","year":"2019","journal-title":"J. Hypertens."},{"key":"2026091008471102100_cit5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11892-023-01506-2","article-title":"Prevalence of Diabetes\nin Patients with Hyperuricemia\nand Gout: A Systematic Review and Meta-analysis","volume":"23","author":"Jiang","year":"2023","journal-title":"Curr. Diab. Rep."},{"key":"2026091008471102100_cit6","doi-asserted-by":"publisher","DOI":"10.1097\/HPC.0000000000000388","article-title":"Hyperuricemia\nand Cardiovascular Risk: Insights and Implications","volume":"24","author":"Shubietah","year":"2025","journal-title":"Crit. Pathw. Cardiol."},{"key":"2026091008471102100_cit7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45034-1","article-title":"Increased risk of chronic\nkidney disease in uric acid stone formers with high neutrophil-to-lymphocyte\nratio","volume":"13","author":"Tung","year":"2023","journal-title":"Sci. Rep."},{"key":"2026091008471102100_cit8","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1045805","article-title":"Dietary intake of fructose\nincreases purine de novo synthesis: A crucial mechanism for hyperuricemia","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Nutr."},{"key":"2026091008471102100_cit9","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/molbev\/msw116","article-title":"Coevolution of URAT1\nand uricase during primate evolution: implications for serum urate\nhomeostasis and gout","volume":"33","author":"Tan","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"2026091008471102100_cit10","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13980","article-title":"Uric acid transport,\ntransporters, and their pharmacological targeting","volume":"238","author":"Adomako","year":"2023","journal-title":"Acta. Physiol(Oxf)."},{"key":"2026091008471102100_cit11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/ki.2010.206","article-title":"A \u2019complexity\u2019\nof urate transporters","volume":"78","author":"Wright","year":"2010","journal-title":"Kidney Int."},{"key":"2026091008471102100_cit12","doi-asserted-by":"publisher","first-page":"15501","DOI":"10.1073\/pnas.0904411106","article-title":"Glut9 is a major regulator\nof urate homeostasis and its genetic inactivation induces hyperuricosuria\nand urate nephropathy","volume":"106","author":"Preitner","year":"2009","journal-title":"Proc. Natl. Acad. Sci.\nU. S. A."},{"key":"2026091008471102100_cit13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1523-1755.2003.00710.x","article-title":"Urate transport via human PAH transporter\nhOAT1 and its gene structure","volume":"63","author":"Ichida","year":"2003","journal-title":"Kidney Int."},{"key":"2026091008471102100_cit14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000074539","article-title":"Human organic anion\ntransporter 3 (hOAT3) can operate as an exchanger and mediate secretory\nurate flux","volume":"13","author":"Bakhiya","year":"2003","journal-title":"Cell Physiol. Biochem."},{"key":"2026091008471102100_cit15","doi-asserted-by":"publisher","first-page":"26107","DOI":"10.1074\/jbc.M110.122721","article-title":"Type 1 sodium-dependent\nphosphate\ntransporter (SLC17A1 Protein) is a Cl(\u2212)-dependent urate exporter","volume":"285","author":"Iharada","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2026091008471102100_cit16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1006\/bbrc.2000.2407","article-title":"p-aminohippuric\nacid transport at renal apical membrane mediated by human inorganic\nphosphate transporter NPT1","volume":"270","author":"Uchino","year":"2000","journal-title":"Biochem. Biophys.\nRes. Commun."},{"key":"2026091008471102100_cit17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","article-title":"Transport\nmechanism and structural pharmacology of\nhuman urate transporter URAT1","volume":"34","author":"Dai","year":"2024","journal-title":"Cell Res."},{"key":"2026091008471102100_cit18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86662-9","article-title":"Hypouricemic agents\nreduce indoxyl sulfate excretion by inhibiting the renal transporters\nOAT1\/3 and ABCG2","volume":"11","author":"Taniguchi","year":"2021","journal-title":"Sci. Rep."},{"key":"2026091008471102100_cit19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015214","article-title":"Benzbromarone\nas a possible cause of acute kidney injury in patients with urolithiasis:\nTwo case reports","volume":"98","author":"Ye","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2026091008471102100_cit20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/ckj\/sfx036","article-title":"Lesinurad: what the\nnephrologist should know","volume":"10","author":"Sanchez-Nin\u0303o","year":"2017","journal-title":"Clin. Kidney J."},{"key":"2026091008471102100_cit21","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/s41594-023-01144-y","article-title":"OAT1 structures\nreveal insights into drug transport in the kidney","volume":"30","author":"Chang","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026091008471102100_cit22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular\nidentification\nof a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"2026091008471102100_cit23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56843-5","article-title":"Mechanisms of urate\ntransport and uricosuric drugs inhibition in\nhuman URAT1","volume":"16","author":"Guo","year":"2025","journal-title":"Nat. Commun."},{"key":"2026091008471102100_cit24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41594-023-01039-y","article-title":"Molecular\nbasis for selective uptake and elimination of organic anions in the\nkidney by OAT1","volume":"30","author":"Parker","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026091008471102100_cit25","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41594-023-01123-3","article-title":"The substrate\nand inhibitor binding mechanism of polyspecific transporter OAT1 revealed\nby high-resolution cryo-EM","volume":"30","author":"Dou","year":"2023","journal-title":"Nat. Struct. Mol.\nBiol."},{"key":"2026091008471102100_cit26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62645-6","article-title":"Discovery\nof multi-target anti-gout agents from Eurycoma longifolia Jack through\nphenotypic screening and structural optimization","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"2026091008471102100_cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168141","article-title":"CavityPlus 2022 Update: An Integrated\nPlatform for Comprehensive Protein Cavity Detection and Property Analyses\nwith User-friendly Tools and Cavity Databases","volume":"435","author":"Wang","year":"2023","journal-title":"J. Mol. Biol."},{"key":"2026091008471102100_cit28","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","article-title":"FAF-Drugs4:\nfree ADME-tox filtering computations for chemical biology and early\nstages drug discovery","volume":"33","author":"Lagorce","year":"2017","journal-title":"Bioinformatics"},{"key":"2026091008471102100_cit29","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1021\/acs.jcim.3c00692","article-title":"VenomPred 2.0: A novel in silico platform for an extended\nand human interpretable toxicological profiling of small molecules","volume":"64","author":"Di Stefano","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"2026091008471102100_cit30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10822-020-00315-z","article-title":"Advances in exploring\nactivity cliffs","volume":"34","author":"Stumpfe","year":"2020","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"2026091008471102100_cit31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/jm401120g","article-title":"Recent progress in understanding\nactivity cliffs and their utility in medicinal chemistry","volume":"57","author":"Stumpfe","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026091008471102100_cit32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.adp0974","article-title":"Sulfenylnitrene-mediated\nnitrogen-atom insertion for late-stage skeletal editing of N-heterocycles","volume":"387","author":"Ghosh","year":"2025","journal-title":"Science"},{"key":"2026091008471102100_cit33","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1021\/acs.jmedchem.0c00564","article-title":"Nitrogen-Walk Approach to Explore Bioisosteric Replacements\nin a Series of Potent A2B Adenosine Receptor Antagonists","volume":"63","author":"Mallo-Abreu","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026091008471102100_cit34","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00210-023-02451-3","article-title":"Berberine attenuates uric acid-induced\ncell injury by inhibiting NLRP3 signaling pathway in HK-2 cells","volume":"396","author":"Zheng","year":"2023","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"2026091008471102100_cit35","doi-asserted-by":"publisher","first-page":"10829","DOI":"10.1021\/acs.jmedchem.0c00223","article-title":"Novel human urate transporter\n1 inhibitors as hypouricemic drug candidates with favorable druggability","volume":"63","author":"Zhao","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026091008471102100_cit36","doi-asserted-by":"publisher","first-page":"13099","DOI":"10.1021\/acs.jmedchem.6c00058","article-title":"Pyridoimidazolyl\nsulfonamide compound 2: a superior dual-acting drug candidate with\npotent URAT1 inhibition and anti-inflammatory activity for gout management","volume":"69","author":"Shi","year":"2026","journal-title":"J. Med. Chem."},{"key":"2026091008471102100_cit37","doi-asserted-by":"publisher","first-page":"10764","DOI":"10.1021\/acs.jmedchem.6c00005","article-title":"A novel pyrrole\nacylsulfonamide,\ncompound 42, as a dual URAT1\/GLUT9 inhibitor: potent urate-lowering\nefficacy, reduced off-target effects, and promising druggability for\nhyperuricemia","volume":"69","author":"Wang","year":"2026","journal-title":"J. Med. Chem."},{"key":"2026091008471102100_cit38","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1677560","article-title":"Aloe-emodin attenuates hyperuricemia-induced\nrenal injury in mice by mitigating inflammation and oxidative stress","volume":"12","author":"Wang","year":"2025","journal-title":"Front Nutr."},{"key":"2026091008471102100_cit39","doi-asserted-by":"publisher","DOI":"10.3390\/cells13050450","article-title":"A Possible\nTherapeutic Application of the Selective Inhibitor of Urate Transporter\n1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and\nCardiovascular Disease","volume":"13","author":"Yanai","year":"2024","journal-title":"Cells."},{"key":"2026091008471102100_cit40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1021\/acsmedchemlett.5c00204","article-title":"Discovery and Optimization\nof 6-Azaindole URAT1 Inhibitors to Address\nKidney and Liver Related Toxicities","volume":"16","author":"Jin","year":"2025","journal-title":"ACS Med.\nChem. Lett."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01923","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20911\/66549067\/acs.jmedchem.6c01923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20911\/66549067\/acs.jmedchem.6c01923.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:03:20Z","timestamp":1789045400000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/17\/20911\/5255670\/Rational-Design-of-Azaindole-Derivatives-via-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":40,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,9,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01923","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}